A few days ago, Baker Hughes (NYSE:BHI) came out with some data regarding the global rig count. During a time when oil production continues to fall in the U.S., as well as in other countries in the world like China and Venezuela, but prices are rising, fears are arising that the uptick in the rig count will result in more production coming on-line moving forward – which, if true, would prolong or maybe even worsen the oil market recovery. In what follows, I will dig into the data provided by the company and give my assessment of the overall market and what it means for investors in companies like Memorial Production Partners (NASDAQ:MEMP), Approach Resources (NASDAQ:AREX), and Legacy Reserves (NASDAQ:LGCY), as well as for the United States Oil ETF (NYSEARCA:USO) and other oil-related ETFs moving forward.
As a disclosure, I should mention that the recent monthly data provided by Baker Hughes pertaining to the rig count incorporates not only oil rigs, but natural gas rigs as well. As much as I wish that the data was broken down into both categories, that’s not how it’s presented. Having said that, this isn’t necessarily a problem, because in its Drilling Productivity Report, the EIA (Energy Information Administration) assumes that all rigs produce a blend of the two – so its own estimates look at the overall rig count, not rig counts that are divided.
stock market update: Aimmune Therapeutics, Inc.(AIMT)
- [By Lisa Levin]
Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.
Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
- [By Jim Robertson]
Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.
- [By Lisa Levin] Gainers
Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
stock market update: Jewett-Cameron Trading Company(JCTCF)
- [By Lisa Levin]
Jewett-Cameron Trading Company Ltd (NASDAQ: JCTCF) shares shot up 11 percent to $13.35. Jewett-Cameron reported Q3 earnings of $0.53 per share on revenue of $16.7 million.
stock market update: Berkshire Hathaway Inc. (BRK-A)
- [By Paul Ausick]
Among other stories related to the company last week, Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) reported that it now owns about 57.4 million shares of Apple stock, up from 15.23 million at the end of the third quarter of 2016.
- [By John Maxfield]
Stocks are up across the board since the presidential election, boosting the value of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio, but few stocks have rallied as much as Bank of America (NYSE:BAC).
- [By Matthew Frankel]
I won’t keep you in suspense — Warren Buffett-led Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) owns 400,000,000 shares of Coca-Cola (NYSE:KO), worth a total of $16.7 billion as of this writing. This translates to a 9.4% stake in the beverage giant, and makes Coca-Cola Buffett’s third-largest stock investment.
- [By Jon C. Ogg]
Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2016. Outside of WarrenBuffett being one of the richest men alive and being considered the greatest investor of modern times, there have been many key changes in the Buffett stocks over recent quarters.
stock market update: Honeywell International Inc.(HON)
- [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
- [By Ben Levisohn]
Honeywell International (HON) is doing what its bigger industrial competitor General Electric (GE) can’t–beating earnings forecasts and seeing its shares gains.
Honeywell reported a profit of $1.66 a share, beating estimates for $1.62 a share, on sales of $9.49 billion, beating forecasts for $9.33 billion. Honeywell also lifted the bottom end of its full-year guidance range to $6.90, from $6.85.
Vertical Research Partners’ Robert Stallard digs into Honeywell’s guidance:
Honeywell continues to expect that the aftermarket in air transport (supported by 4-5% flight hour growth) will grow faster than at BGA (with declining flight hours in BGA expected). For bizjet, Honeywell reiterated that it isnt anticipating an OE recovery until the 2018/19 timeframe. It expects Q2 Aerospace sales to be flat to down 2% on the similar trends of air transport aftermarket growth being offset by ongoing softness in BGA and Space, and noted that Q2 should be the last quarter of OE incentive headwinds (H2 moving to a ~$70m tailwind versus a ~$25m headwind in H1).
Shares of Honeywell have gained 2.6% to $126.96 at 2:54 p.m. today, while General Electric has fallen 1.9% to $29.70 after reporting earnings. The Industrial Select Sector SPDR ETF (XLI) has advanced 0.2% to $65.48.
- [By Laurie Kulikowski]
The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Aerospace & Defense industry average. The net income increased by 8.3% when compared to the same quarter one year prior, going from $1,167.00 million to $1,264.00 million.
- [By Paul Ausick]
According to a report at Bloomberg News, some of the companies sending representatives along include General Electric Co. (NYSE: GE), Honeywell International Inc. (NYSE: HON), Boeing Co. (NYSE: BA), and Qualcomm Inc. (NASDAQ: QCOM). One company that has said it is not participating in the trip is Caterpillar Inc. (NYSE: CAT).
- [By Laurie Kulikowski]
HONEYWELL INTERNATIONAL INC has improved earnings per share by 8.8% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, HONEYWELL INTERNATIONAL INC increased its bottom line by earning $5.33 versus $4.92 in the prior year. This year, the market expects an improvement in earnings ($6.10 versus $5.33).